Are large when compared with present-day cefepime breakpoints, better breakpoints of cefepime/zidebactam may be warranted for Acinetobacter The real consequences of the new cefepime mixtures will likely only be recognized when tested in opposition to severe MDR infections in very well-conducted pragmatic randomized trials. et al. New insights in to https://lechm887bmx0.daneblogger.com/profile